Bank of America’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.5M | Buy |
|
|||||
|
2025
Q2 | $4.03M | Sell |
|
|||||
|
2025
Q1 | $6.72M | Buy |
|
|||||
|
2024
Q4 | $7.46M | Sell |
|
|||||
|
2024
Q3 | $14.7M | Buy |
|
|||||
|
2024
Q2 | $14.5M | Buy |
|
|||||
|
2024
Q1 | $17.2M | Buy |
|
|||||
|
2023
Q4 | $11.6M | Sell |
|
|||||
|
2023
Q3 | $13.1M | Buy |
|
|||||
|
2023
Q2 | $16.7M | Sell |
|
|||||
|
2023
Q1 | $50M | Buy |
|
|||||
|
2022
Q4 | $24M | Buy |
|
|||||
|
2022
Q3 | $16.8M | Sell |
|
|||||
|
2022
Q2 | $19.3M | Buy |
|
|||||
|
2022
Q1 | $24.5M | Buy |
|
|||||
|
2021
Q4 | $34.3M | Sell |
|
|||||
|
2021
Q3 | $40.2M | Buy |
|
|||||
|
2021
Q2 | $45.7M | Sell |
|
|||||
|
2021
Q1 | $27.3M | Buy |
|
|||||
|
2020
Q4 | $6.13M | Buy |
|
|||||
|
2020
Q3 | $1.17M | Buy |
|
|||||
|
2020
Q2 | $525K | Sell |
|
|||||
|
2020
Q1 | $437K | Buy |
|
|||||
|
2019
Q4 | $437K | Sell |
|
|||||
|
2019
Q3 | $407K | Sell |
|
|||||
|
2019
Q2 | $1.13M | Sell |
|
|||||
|
2019
Q1 | $1.76M | Buy |
|
|||||
|
2018
Q4 | $333K | Sell |
|
|||||
|
2018
Q3 | $1.08M | Sell |
|
|||||
|
2018
Q2 | $3.45M | Buy |
|
|||||
|
2018
Q1 | $223K | Buy |
|
|||||
|
2017
Q4 | $173K | Sell |
|
|||||
|
2017
Q3 | $657K | Buy |
|
|||||
|
2017
Q2 | $405K | Buy |
|
|||||
|
2017
Q1 | $251K | Buy |
|
|||||
|
2016
Q4 | $43K | Buy |
|
|||||
|
2016
Q3 | $11K | Buy |
|
|||||
|
2016
Q2 | $3K | Buy |
|